Last news
Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board

Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board

Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth Bambusa also forms a Scientific Advisory Board of globally recognized leaders in biopharma, dermatology, and respiratory...

Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research

Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response MORRISVILLE, N.C., July 15, 2026 /PRNewswire/ --...

LifeZoom Launches Veyra, a Lightweight Curved Red Light Device for Stand, Belt, and Dome-Style Use

LifeZoom Launches Veyra, a Lightweight Curved Red Light Device for Stand, Belt, and Dome-Style Use

NEW YORK, July 15, 2026 /PRNewswire/ -- LifeZoom today announced the launch of Veyra, a lightweight curved silicone red light therapy device for those who want to add red light care to their daily routines in a more natural way. Created for...

XGIMI Redefines Portable Projection with the Expanded Elfin Flip Series, Led by the Elfin Flip 4K -- Its Flagship Portable 4K Laser Projector

XGIMI Redefines Portable Projection with the Expanded Elfin Flip Series, Led by the Elfin Flip 4K -- Its Flagship Portable 4K Laser Projector

The new Elfin Flip Series ends the trade-off between portability and performance — bringing 4K laser visuals, Harman Kardon audio, and 1ms gaming latency into a book-sized form factor built for life at home. SHENZHEN, China, July 15, 2026...

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia-associated bacterial pathogens Global Million...

NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report

NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 15, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...

Dao by Dorsett AMTD Singapore Honoured with Tripadvisor Travellers' Choice 2026, Recognised Among the Top 10% of Properties Worldwide

Dao by Dorsett AMTD Singapore Honoured with Tripadvisor Travellers' Choice 2026, Recognised Among the Top 10% of Properties Worldwide

PARIS and NEW YORK and LONDON, July 15, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA") (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. ("AMTD Digital") (NYSE: HKD) and The Generation Essentials Group ("TGE") (NYSE: TGE;...

Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS

Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS

— Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — — First-in-Human trial met primary safety endpoints with no Serious Adverse...

1 ... 9 10 11 12 13 14 15 16 17 ... 5035
menu
menu